|
1.
|
Kearney PM, Whelton M, Reynolds K, Muntner
P, Whelton PK and He J: Global burden of hypertension: analysis of
worldwide data. Lancet. 365:217–223. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Primary hypertension: Pathogenesis.
Kaplan’s Clinical Hypertension. Kaplan NM: 9th edition. Lippincott
Williams & Wilkins; Philadelphia, PA: pp. 50–121. 2006
|
|
3.
|
Niu W, Wu S, Zhang Y, Li W, Ji K, Gao P
and Zhu D: Validation of genetic association in apelin-AGTRL1
system with hypertension in a larger Han Chinese population. J
Hypertens. 28:1854–1861. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Niu W, Qi Y, Hou S, Zhai X, Zhou W and Qiu
C: Haplotype-based association of the renin-angiotensin-aldosterone
system genes polymorphisms with essential hypertension among Han
Chinese: the Fangshan study. J Hypertens. 27:1384–1391. 2009.
View Article : Google Scholar
|
|
5.
|
Kurtz TW: Genome-wide association studies
will unlock the genetic basis of hypertension: con side of the
argument. Hypertension. 56:1021–1025. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Carlos MI: Calcium, hypertension and
target organ damage: from prevention to regression. Rev Latinoam
Hiperte. 2:24–28. 2007.
|
|
7.
|
Atlas SA, Volpe M, Sosa RE, Laragh JH,
Camargo MJ and Maack T: Effects of atrial natriuretic factor on
blood pressure and the renin-angiotensin-aldosterone system. Fed
Proc. 45:2115–2121. 1986.PubMed/NCBI
|
|
8.
|
Wang SZ, Zhang YM and Cheng ZH: The
epidemiological factors in different ethnic hypertension of the
Xinjiang Uygur Autonomous Region. China Cardiovascular Magazine.
12:179–182. 1984.(In Chinese).
|
|
9.
|
McKie PM, Ichiki T and Burnett JC Jr:
M-atrial natriuretic peptide: a novel antihypertensive protein
therapy. Curr Hypertens Rep. 14:62–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Zhang S, Mao G, Zhang Y, et al:
Association between human atrial natriuretic peptide Val7Met
polymorphism and baseline blood pressure, plasma trough irbesartan
concentrations, and the antihypertensive efficacy of irbesartan in
rural Chinese patients with essential hypertension. Clin Ther.
27:1774–1784. 2005. View Article : Google Scholar
|
|
11.
|
Writing Group of 2010 Chinese guidelines
for the management of hypertension: 2010 Chinese guidelines for the
management of hypertension. Chin J Hypertension. 19:701–743.
2010.
|
|
12.
|
Cook NR, Obarzanek E, Cutler JA, et al:
Joint effects of sodium and potassium intake on subsequent
cardiovascular disease: the Trials of Hypertension Prevention
follow-up study. Arch Intern Med. 169:32–40. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Umesawa M, Iso H, Date C, et al: Relations
between dietary sodium and potassium intakes and mortality from
cardiovascular disease: the Japan Collaborative Cohort Study for
Evaluation of Cancer Risks. Am J Clin Nutr. 88:195–202.
2008.PubMed/NCBI
|
|
14.
|
He FJ, Marciniak M, Visagie E, et al:
Effect of modest salt reduction on blood pressure, urinary albumin,
and pulse wave velocity in white, black, and Asian mild
hypertensives. Hypertension. 54:482–488. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Polónia J, Maldonado J, Ramos R, et al:
Estimation of salt intake by urinary sodium excretion in a
Portuguese adult population and its relationship to arterial
stiffness. Rev Port Cardiol. 25:801–817. 2006.PubMed/NCBI
|
|
16.
|
Jablonski KL, Gates PE, Pierce GL and
Seals DR: Low dietary sodium intake is associated with enhanced
vascular endothelial function in middle-aged and older adults with
elevated systolic blood pressure. Ther Adv Cardiovasc Dis.
3:347–356. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Hu J, Jiang X, Li N, et al: Effects of
salt substitute on pulse wave analysis among individuals at high
cardiovascular risk in rural China: a randomized controlled trial.
Hypertens Res. 32:282–288. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Whelton PK: Potassium and blood pressure.
Hypertension Primer. Izzo JL and Black HR: 3rd edition. Lippincott
Williams & Wilkins; Philadelphia, PA: pp. 280–282. 2003
|
|
19.
|
He FJ and MacGregor GA: Fortnightly
review: Beneficial effects of potassium. BMJ. 323:497–501. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Panel on Dietary Reference Intakes for
Electrolytes and Water; Standing Committee on the Scientific
Evaluation of Dietary Reference Intakes: Dietary Reference Intakes
for Water, Potassium, Sodium, Chloride, and Sulfate. National
Academies Press; Washington, DC: pp. 17–223. 2005
|
|
21.
|
He BP, Wu QY, Pan YJ, et al: Study on
measurement of trace element iron content in patients with
hypertension and its significance. Chin Clin Med. 5:11–12. 2004.(In
Chinese).
|
